FSHD University webinar featuring FSHD ETN chair Dr. Nicol Voermans

W​​​​hile FSHD patients wait for new drugs to slow the progression of muscle weakness, Dr. Voermans emphasizes that there are many interventions already that can have a significant positive benefit. She encourages everyone with FSHD to do what they can to be as healthy and “trial fit” as possible.